AZTA
Price
$48.31
Change
+$2.00 (+4.32%)
Updated
Dec 18, 10:56 AM (EDT)
55 days until earnings call
NEO
Price
$17.53
Change
-$0.44 (-2.45%)
Updated
Dec 17, 04:59 PM (EDT)
69 days until earnings call
Ad is loading...

AZTA vs NEO

Header iconAZTA vs NEO Comparison
Open Charts AZTA vs NEOBanner chart's image
Azenta
Price$48.31
Change+$2.00 (+4.32%)
Volume$2.06K
CapitalizationN/A
NeoGenomics
Price$17.53
Change-$0.44 (-2.45%)
Volume$17.89K
CapitalizationN/A
AZTA vs NEO Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. NEO commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and NEO is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AZTA: $46.31 vs. NEO: $17.55)
Brand notoriety: AZTA and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 95% vs. NEO: 127%
Market capitalization -- AZTA: $3.36B vs. NEO: $2.01B
AZTA [@Medical Specialties] is valued at $3.36B. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, NEO is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 2 TA indicator(s) are bullish while NEO’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 2 bullish, 5 bearish.
  • NEO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NEO is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Medical Specialties) experienced а -0.11% price change this week, while NEO (@Medical Specialties) price change was -4.77% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.64%. For the same industry, the average monthly price growth was +3.54%, and the average quarterly price growth was +6.04%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 11, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-2.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than NEO($2.01B). NEO YTD gains are higher at: 8.467 vs. AZTA (-28.907). AZTA has higher annual earnings (EBITDA): 57.5M vs. NEO (-17.61M). AZTA has more cash in the bank: 984M vs. NEO (415M). AZTA has less debt than NEO: AZTA (66.5M) vs NEO (612M). AZTA has higher revenues than NEO: AZTA (641M) vs NEO (592M).
AZTANEOAZTA / NEO
Capitalization3.36B2.01B168%
EBITDA57.5M-17.61M-327%
Gain YTD-28.9078.467-341%
P/E RatioN/A49.50-
Revenue641M592M108%
Total Cash984M415M237%
Total Debt66.5M612M11%
FUNDAMENTALS RATINGS
AZTA vs NEO: Fundamental Ratings
AZTA
NEO
OUTLOOK RATING
1..100
5616
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9093
PRICE GROWTH RATING
1..100
6145
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (71) in the Medical Or Nursing Services industry is in the same range as AZTA (72) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's Profit vs Risk Rating (93) in the Electronic Production Equipment industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

AZTA's SMR Rating (90) in the Electronic Production Equipment industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (45) in the Medical Or Nursing Services industry is in the same range as AZTA (61) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (62) in the Electronic Production Equipment industry is somewhat better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew somewhat faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTANEO
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 10 days ago
73%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+4.09%
CRL - AZTA
58%
Loosely correlated
-0.39%
BLFS - AZTA
52%
Loosely correlated
-1.83%
IQV - AZTA
52%
Loosely correlated
-0.23%
RGEN - AZTA
49%
Loosely correlated
-1.73%
TWST - AZTA
47%
Loosely correlated
-0.06%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-2.34%
FLGT - NEO
48%
Loosely correlated
-1.12%
VCYT - NEO
42%
Loosely correlated
-2.52%
AZTA - NEO
42%
Loosely correlated
+4.09%
CRL - NEO
41%
Loosely correlated
-0.39%
AORT - NEO
40%
Loosely correlated
-0.21%
More